Live Quote · NASDAQROIVHealthcare· Biotechnology

Roivant Sciences Ltd.

$38.66▼ 0.78%($-0.30)
MKT CAP $28.01BNEXT EARNINGS Feb 5, 2027
50%
Bullish
TickerSpark Score
55/100
▌ Mixed
55
Valuation
40
Profitability
10
Growth
72
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ROIV research report →

Analyst Price Target
$49.50+28.1% vs. today

Range $41 – $62

Analyst RatingBuy
14 Buy2 Hold0 Sell

Price Chart

+90.73% · this period
$41.85$30.98$20.10Nov 20May 26Nov 20
52-Week Range83% of range
Low
$19.96
Current
$38.66
High
$42.50

AI analysis · Last refreshed November 14, 2026 · Live quote · Not investment advice